Mode
Text Size
Log in / Sign up

OB/GYN & Women's Health

294 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Specific histological features improve the differentiation between fibroadenomas and phyllodes tumors in core needle biopsies
OB/GYN & Women's Health Meta-analysis
Specific histological features improve the differentiation between fibroadenomas and phyllodes tumors in core needle biopsies Specific Tissue Features Help Distinguish Phyllodes Tumors From Fibroadenomas
Researchers evaluated various histological characteristics to distinguish between fibroadenomas and phyllodes tumors in core needle biopsy s…
New research identifies specific tissue patterns in needle biopsies to help doctors better distinguish between fibroadenomas and phyllodes t…
Breast cancer survival in Ghana: median OS 4.4 years, 5-year rate 46.5%
OB/GYN & Women's Health Meta-analysis
Breast cancer survival in Ghana: median OS 4.4 years, 5-year rate 46.5% New data shows breast cancer survival rates in Ghana
This meta-analysis pooled data from 2114 patients with breast cancer in Ghana, reporting a median overall survival of 4.4 years and a 5-year…
A look at over 2,000 cases reveals that the median survival for breast cancer patients in Ghana is about 4.4 years.
Robot-assisted mastectomy with immediate reconstruction reduces overall complication risk compared to conventional mastectomy
OB/GYN & Women's Health Meta-analysis
Robot-assisted mastectomy with immediate reconstruction reduces overall complication risk compared to conventional mastectomy Robot assisted surgery may lower complication risks in breast cancer
This systematic review and meta-analysis of 3,985 patients found that robot-assisted mastectomy (RAM) with immediate breast reconstruction r…
Robot assisted mastectomy can lead to fewer overall complications and less blood loss during immediate breast reconstruction for some patien…
Datopotamab deruxtecan improves progression-free survival to 10.8 months versus 5.6 months in TNBC
OB/GYN & Women's Health RCT
Datopotamab deruxtecan improves progression-free survival to 10.8 months versus 5.6 months in TNBC Trial shows datopotamab deruxtecan improves survival in triple-negative breast cancer
This Phase III randomized controlled trial of 644 patients with untreated, locally recurrent inoperable or metastatic triple-negative breast…
A new trial shows that datopotamab deruxtecan may extend progression-free and overall survival for patients with advanced triple-negative br…
Inositol supplementation reduces total testosterone and improves SHBG levels in women with polycystic ovary syndrome
OB/GYN & Women's Health Meta-analysis
Inositol supplementation reduces total testosterone and improves SHBG levels in women with polycystic ovary syndrome Inositol may lower testosterone levels in women with PCOS
This meta-analysis of randomized controlled trials involving 440 women with polycystic ovary syndrome found that inositol supplementation si…
New data shows that inositol supplements can help lower high testosterone and improve hormone balance for some women with PCOS.
CBSM increases likelihood of MVPA engagement in breast cancer survivors
OB/GYN & Women's Health RCT
CBSM increases likelihood of MVPA engagement in breast cancer survivors Cognitive Behavioral Stress Management Helps Breast Cancer Patients Exercise More
This randomized controlled trial of 240 women with Stage 0-III breast cancer found that a 10-week group cognitive behavioral stress manageme…
A new study shows that a 10-week stress management program helps women with breast cancer become more likely to engage in regular physical a…
Activity trackers with walking programs increase activity levels in early-stage breast cancer patients
OB/GYN & Women's Health RCT
Activity trackers with walking programs increase activity levels in early-stage breast cancer patients Activity Trackers Help Breast Cancer Patients Maintain Exercise Levels
This randomized controlled trial of 320 patients receiving aromatase inhibitor therapy found that a 24-week walking program with an activity…
A new study shows that using a wearable activity tracker helps women with breast cancer maintain consistent exercise habits over two years.
FNAC using WHO reporting system shows 87.01% diagnostic accuracy for breast lesions in women aged 40
OB/GYN & Women's Health Meta-analysis
FNAC using WHO reporting system shows 87.01% diagnostic accuracy for breast lesions in women aged 40 Fine needle tests show high accuracy for young women's breast lesions
This meta-analysis of observational studies and case series evaluates the diagnostic performance of FNAC using the WHO reporting system in w…
A fine needle aspiration test shows high reliability for identifying cancer in women under 40, helping doctors manage suspicious results mor…
Cervical cancer patients face mean treatment delays of 71.42 days from histopathological diagnosis
OB/GYN & Women's Health Meta-analysis
Cervical cancer patients face mean treatment delays of 71.42 days from histopathological diagnosis Cervical cancer treatment delays average 71 days
This meta-analysis evaluates the time elapsed between histopathological diagnosis and first-line definitive treatment for cervical cancer. T…
A global review finds cervical cancer patients wait about 71 days for treatment, with longer delays in middle-income countries.
PTEN IHC shows moderate diagnostic accuracy for differentiating atypical endometrial hyperplasia from non-atypical cases
OB/GYN & Women's Health Meta-analysis
PTEN IHC shows moderate diagnostic accuracy for differentiating atypical endometrial hyperplasia from non-atypical cases New test marker helps identify high risk uterine tissue
This meta-analysis of 2274 women evaluated the diagnostic accuracy of PTEN immunohistochemical markers in distinguishing atypical endometria…
A specific protein marker can help doctors tell the difference between precancerous and cancerous uterine tissues to avoid unnecessary surge…
Contrast-enhanced mammography shows 100% NPV for non-enhancing asymmetries in breast cancer screening
OB/GYN & Women's Health Meta-analysis
Contrast-enhanced mammography shows 100% NPV for non-enhancing asymmetries in breast cancer screening Contrast-Enhanced Mammography Helps Identify Risks in Breast Cancer Screening
This meta-analysis of retrospective studies evaluated the role of contrast-enhanced mammography (CEM) in assessing mammographic asymmetries.…
New imaging techniques help doctors better identify the risk of cancer in breast tissue that appears unusual on standard mammograms.
Progestin-only subdermal implants linked to 23% higher breast cancer risk in younger women
OB/GYN & Women's Health Meta-analysis
Progestin-only subdermal implants linked to 23% higher breast cancer risk in younger women Progestin Only Subdermal Implants Linked to Higher Breast Cancer Risk
This meta-analysis of observational studies found that progestin-only subdermal implant use is associated with a higher incident breast canc…
A review of data suggests that using progestin only subdermal implants may be linked to a higher risk of breast cancer in some women.